Summit Therapeutics (SMMT) Stock Price Target 2026

The average analyst price target for Summit Therapeutics is $31.86, 95.5% above the current price. Of 17 analysts, 13 rate it Buy and 4 Hold. Targets range from $11.90 to $44. The latest change came on Oct 1, 2026, when Barclays raised its price target on Summit Therapeutics from $18 to $20 and kept an Equal-Weight rating.